Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Exploring Emerging Novel Metabolic Biomarkers of Atherosclerosis"
A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Frontiers in Metabolomics".
Deadline for manuscript submissions: closed (28 February 2023) | Viewed by 3539
Special Issue Editors
2. Department of Cardiology and Congenital Diseases of Adults, Polish Mother’s Memorial Hospital Research Institute (PMMHRI), 93-338 Lodz, Poland
Interests: disorders of lipid metabolism; atherosclerosis; hypertension; preventive medicine; drug development; risk stratification
2. Division of Vascular Surgery, St. Michael’s Hospital, Toronto, ON, Canada
Interests: vascular surgery; peripheral arterial disease; biomarkers; prognostication; abdominal aortic aneurysm; thrombosis; atherosclerosis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Atherosclerotic diseases remain a leading cause of disability, morbidity and mortality worldwide, partly due to a paucity of adequate diagnostic tools. The critical need for novel and improved diagnostic modalities for certain atherosclerotic diseases (peripheral arterial disease, carotid artery stenosis etc.) warrant the discovery and emergence of specific yet sensitive biomarkers, but this area of research has historically been understudied.
New genetic biomarkers, novel biochemical biomarkers that might significantly add to better risk stratification and the study of metabolomics represent unique opportunities to advance precision-based medicine for atherosclerotic diseases by investigating their molecular phenotype. For this Special Issue titled “Exploring Emerging Novel Metabolic Biomarkers of Atherosclerosis”, we invite submissions exploring novel biomarkers and personalized medicine options for a variety of atherosclerotic diseases.
Dr. Maciej Banach
Dr. Mohammad Qadura
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- molecular biomarkers
- mass spectrometry
- nuclear magnetic resonance
- peripheral artery disease
- risk stratification
- coronary artery disease
- carotid artery stenosis